⚡ Quick Answer — What is Prazopress?
Prazopress este un 1 mg Prazosin (immediate-release) tablet from Sun Pharma — a selective alpha-1 adrenergic receptor antagonist (quinazoline structure), acting on post-synaptic alpha-1 adrenergic receptors on arterial and venous smooth muscle, and on prostatic/bladder-neck smooth muscle. Prazosin was introduced by Pfizer in 1974 as Minipress — the first selective alpha-1 antagonist and the template for the entire alpha-blocker class. Immediate-release prazosin has been largely displaced in hypertension by newer classes, but remains clinically important for PTSD-related nightmares (off-label) and for selective benign prostatic hyperplasia (BPH) cases. Half-life 2-3 hours (short — requires twice- or three-times-daily dosing); onset 30-90 minutes; peak plasma 1-3 hours; duration 4-10 hours depending on dose. Primary indications: PTSD-associated nightmares (off-label; primary modern use), resistant hypertension as add-on, benign prostatic hyperplasia. Typical dosing: Hypertension: start 0.5-1 mg at bedtime for the first dose (the “first-dose phenomenon” — see below), then 1 mg 2-3 times daily, titrating to 2-20 mg/day in divided doses. Not a first-line antihypertensive. ALLHAT discontinued the doxazosin arm early for excess heart failure, making modern guidelines reserve alpha-blockers as fourth/fifth-line agents for resistant HTN. Always start the first dose at bedtime — the “first-dose” phenomenon causes severe orthostatic hypotension in the opening hours. Not a first-line antihypertensive (ALLHAT class concerns) — reserve for fourth/fifth-line use, especially where BPH coexists. For most hypertensive patients, modern treatment starts with an ACE inhibitor/ARB, a calcium-channel blocker, a thiazide, and spironolactone before reaching for an alpha-blocker or centrally-acting agent.
📦 Fiecare comandă este acoperită de politica noastră de Politica noastră de Reexpediere Garantată — dacă coletul dumneavoastră nu sosește în 20 de zile lucrătoare, îl relivrăm.
De ce să comanzi de la MedsBase
Medicamentele noastre generice sunt procurate de la producători certificați WHO-GMP și expediate la nivel mondial în ambalaje discrete și simple — fără denumirea medicamentului pe exteriorul coletului. Plățile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de plăți cu card reglementat — niciodată “MedsBase” sau numele vreunui medicament). Acceptăm și criptomonede și transferuri bancare SEPA. Fiecare comandă este susținută de Politica noastră de Asigurare pentru Relivrare.
What Is Prazopress?
Prazopress is an oral 1 mg Prazosin (immediate-release) tablet from Sun Pharma, supplied in 30-90 tablets. Prazosin was introduced by Pfizer in 1974 as Minipress — the first selective alpha-1 antagonist and the template for the entire alpha-blocker class. Immediate-release prazosin has been largely displaced in hypertension by newer classes, but remains clinically important for PTSD-related nightmares (off-label) and for selective benign prostatic hyperplasia (BPH) cases.
How Prazosin (immediate-release) Works
Prazosin (immediate-release) acts on post-synaptic alpha-1 adrenergic receptors on arterial and venous smooth muscle, and on prostatic/bladder-neck smooth muscle. The downstream effects:
- Arterial and venous vasodilation — blockade of alpha-1 receptors on vascular smooth muscle reduces systemic vascular resistance; venous dilation reduces preload
- Reduced bladder-neck and prostatic smooth-muscle tone — improves urinary flow in BPH (dominant clinical effect for the XL/long-acting forms)
- Improved lipid profile — modest reduction in LDL and triglycerides, small rise in HDL; metabolically distinct from thiazides and beta-blockers
- Improved insulin sensitivity in some studies — an argument for alpha-blockers in hypertensive patients with metabolic syndrome or type 2 diabetes
- No direct effect on renin or electrolytes — potassium, sodium, and creatinine unaffected (contrast with diuretics and RAAS blockers)
- Reflex tachycardia is blunted compared with direct vasodilators (hydralazine, minoxidil) because of some central sympathetic feedback, but still occurs on initiation
- Central alpha-1 blockade in the locus coeruleus is the proposed mechanism for the PTSD-nightmare benefit — reduces noradrenergic hyperarousal during sleep
Approved and Evidence-Based Uses
- PTSD-associated nightmares (off-label; primary modern use), resistant hypertension as add-on, benign prostatic hyperplasia
- PTSD-associated nightmares and sleep disturbance (off-label) — widely used; Raskind RCT evidence
- Benign prostatic hyperplasia — immediate-release prazosin less convenient than XL
- Raynaud phenomenon (off-label; mixed evidence)
- Pheochromocytoma preoperative preparation — phenoxybenzamine is preferred; prazosin is a short-acting alternative in some protocols
Pivotal trial evidence: VA Cooperative Trial (1982) — prazosin comparable to standard antihypertensives in mild-moderate hypertension; established clinical validity. ALLHAT doxazosin arm (2000) — terminated 3 years early due to 25% excess risk of heart failure vs chlorthalidone; interpreted as a class concern for alpha-blockers in HTN. Raskind et al. PTSD trials (2003, 2007, 2013) — prazosin 1-10 mg at bedtime reduced trauma nightmares and improved sleep in combat and civilian PTSD. PACT (2018) — 304 veterans, prazosin did not outperform placebo for PTSD overall, though subgroup analyses remained supportive.
Prazopress Dosage
Primary dose: Hypertension: start 0.5-1 mg at bedtime for the first dose (the “first-dose phenomenon” — see below), then 1 mg 2-3 times daily, titrating to 2-20 mg/day in divided doses. Not a first-line antihypertensive. ALLHAT discontinued the doxazosin arm early for excess heart failure, making modern guidelines reserve alpha-blockers as fourth/fifth-line agents for resistant HTN.
Other indications: PTSD nightmares (off-label): 1 mg at bedtime initially, titrating by 1 mg every 3-5 days to clinical effect. Typical effective dose 2-10 mg at bedtime; some patients require 15-20 mg. Evidence base: Raskind and Peskind RCTs (2003-2013) showed significant reduction in nightmare frequency and improvement in sleep architecture, though the larger 2018 PACT trial was negative — enthusiasm tempered but use remains common when CBT-I and trauma-focused psychotherapy are inadequate. Benign prostatic hyperplasia: 1-2 mg two or three times daily; extended-release prazosin (XL) is generally preferred for BPH. Raynaud phenomenon: 1-5 mg two or three times daily off-label.
Administration: take with or without food. First dose at bedtime. Regular doses spread 6-8 hours apart.
Monitoring schedule:
- Baseline: supine and standing BP (document postural drop), heart rate, symptom review for dizziness/falls, medication list (check for interacting agents).
- Week 1-2: repeat BP (supine and standing), heart rate, symptom review. Adjust dose up or down based on BP and tolerability.
- Week 4-6: assess target BP; symptom burden; check for BPH symptom response if applicable (IPSS).
- Ongoing: annual BP review, fall/syncope history, cataract history (floppy iris pre-op alert).
- Stop or dose-reduce on: syncope, falls, priapism, floppy iris identification, severe retrograde ejaculation affecting quality of life.
Discontinuation: no rebound syndrome. Alpha-blockers can be stopped but expect some BP rise if they contributed meaningfully to control. Re-initiate at the starting dose (not the previous maintenance dose) if restarting after a gap of >1 week — the first-dose phenomenon returns.
Practical Considerations for Prazopress
- “First-dose phenomenon” — severe orthostatic hypotension, syncope, and reflex tachycardia within 30-90 minutes of the first dose, especially in volume-depleted patients or those already on a diuretic or beta-blocker. Always start 0.5-1 mg at bedtime. Risk diminishes rapidly over the first week as autonomic tone adjusts.
- “Floppy iris syndrome” (intraoperative during cataract surgery) — inform the ophthalmologist of any alpha-blocker history. Can cause iris prolapse and pupillary miosis mid-operation. Does not resolve quickly on stopping the drug.
- Tolerance to the antihypertensive effect can develop over months — partly why alpha-blockers fell out of favour as HTN monotherapy.
- Alcohol potentiates orthostatic hypotension sharply — warn patients especially on initiation.
Efecte Secundare
Common (>1%):
- Orthostatic hypotension and dizziness (especially on standing or after warm showers)
- Fatigue, somnolence
- Dureri de cap
- Palpitations (reflex tachycardia)
- Nasal congestion (alpha-blockade of nasal vasculature)
- Nausea, dry mouth
- Urinary incontinence in women (rare; alpha-blockade of bladder-neck tone)
- Priapism — rare but emergent. Seek urgent care for erection >4 hours.
- Peripheral oedema
Uncommon but clinically important:
- Syncope with loss of consciousness on first dose or rapid titration — dose at bedtime; warn the patient explicitly.
- Priapism — emergent urological referral for erection >4 hours.
- Intraoperative floppy iris syndrome — may cause cataract-surgery complications; alert the ophthalmologist.
- Paradoxical urinary incontinence in women (rare; alpha-blockade of bladder-neck tone).
- Worsening of heart failure — class concern from ALLHAT; caution in HF patients.
- Severe hypotension with PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) — maintain a 4-6 hour gap.
Contraindicații
- Known hypersensitivity to quinazolines (prazosin, doxazosin, terazosin)
- Concurrent PDE-5 inhibitor use (sildenafil, tadalafil, vardenafil) without a strict 4-6 hour gap — additive severe hypotension
- History of orthostatic hypotension, syncope, or severe postural BP drop
- Severe aortic stenosis or significant obstructive valvular lesion
- Pregnancy and breastfeeding (limited data; prefer methyldopa or labetalol)
Pregnancy: avoided — limited pregnancy data for alpha-blockers. Switch to methyldopa, labetalol, or nifedipine for pregnancy hypertension.
Breastfeeding: limited data; use with caution. Switch to an agent with better breastfeeding data (labetalol, nifedipine, enalapril) where possible.
Interacțiuni medicamentoase
- PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) — CRITICAL. Combined use causes severe additive hypotension. Maintain a 4-6 hour gap between alpha-blocker and PDE-5 inhibitor doses; daily-dose tadalafil 5 mg for BPH is contraindicated with alpha-blockers.
- Other antihypertensives — additive BP-lowering. Start low, titrate slowly.
- Beta-blockers — reduced reflex tachycardia can mask hypoglycaemia or acute bleed. Combined use is not contraindicated but may require lower alpha-blocker starting dose.
- Non-dihydropyridine CCBs (verapamil, diltiazem) — additive hypotension.
- Diuretics — volume depletion potentiates first-dose hypotension. Hold diuretic the day of first alpha-blocker dose if possible.
- Tricyclic antidepressants — additive orthostatic hypotension.
- AINS — reduce antihypertensive effect (less than with thiazides/ACEi).
- Alcool — marked additive orthostatic hypotension; warn patients.
Where Prazopress Fits in the Antihypertensive Hierarchy
| Nivel | Class / Examples | Role |
|---|---|---|
| First-line | ACE inhibitors (ramipril), ARBs (telmisartan), CCBs (amlodipine), thiazides (indapamide, HCTZ) | Start here for newly diagnosed HTN |
| Second / third agent | Combinations of the above (ACEi+CCB, ARB+thiazide) | When one agent insufficient |
| Fourth agent (resistant HTN) | Spironolactone (PATHWAY-2 evidence); beta-blocker; doxazosin | If BP uncontrolled on three-drug combination at full dose |
| Fifth agent | Alfa-blocante (prazosin, terazosin, doxazosin); centrally-acting agents | Add if spironolactone inadequate or contraindicated; prefer alpha-blockers where BPH coexists |
| Fifth / sixth agent | Centrally-acting agents (clonidine, moxonidine) | Add to bring resistant HTN to target; watch for rebound and sedation |
| Pregnancy first-line | Methyldopa, labetalol, nifedipine | Gestational HTN and pre-existing HTN during pregnancy |
Depozitare
Store Prazopress below 25°C in the original blister pack. Keep out of reach of children.
Întrebări frecvente
Why is Prazopress not a first-line blood-pressure drug?
The ALLHAT trial stopped its doxazosin arm three years early after finding a 25% excess of heart failure compared with chlorthalidone. The finding was interpreted as an alpha-blocker class concern. Guidelines now place ACE inhibitors, ARBs, calcium-channel blockers, and thiazides as first-line, reserving alpha-blockers as fourth or fifth-line agents. Alpha-blockers remain preferred add-ons where benign prostatic hyperplasia (BPH) coexists with hypertension — one drug for two problems.
What is the “first-dose phenomenon” and how do I avoid it?
The first dose of any alpha-blocker can cause severe orthostatic hypotension — blood pressure drops on standing, sometimes to the point of syncope, within 30-90 minutes of the dose. Risk is highest in volume-depleted patients (those already on diuretics) or those on beta-blockers. To minimise risk: take the first dose at bedtime, stay in bed for the first 2-3 hours, avoid alcohol, hold the diuretic dose if possible on day 1, and titrate doses weekly rather than daily. The risk falls sharply over the first 7-10 days as autonomic adaptation occurs.
Can I take Prazopress with alcohol?
Light, occasional drinking is usually tolerated. Regular or heavy drinking substantially potentiates the orthostatic hypotension of Prazopress — falls, blackouts, and accidents become more likely. Patients at higher risk (elderly, previous falls, concurrent diuretics or sedatives) should avoid alcohol altogether on this medication.
Does prazosin really help PTSD nightmares?
For many patients, yes — but not universally. The evidence base (Raskind and Peskind RCTs, 2003-2013) showed significant reductions in nightmare frequency and improvements in sleep architecture at doses of 2-10 mg at bedtime. The larger PACT trial in 2018 was negative overall, tempering enthusiasm, and current VA/DOD guidance is more cautious than it was in 2015. Many PTSD specialists still use prazosin for distressing trauma-related nightmares when trauma-focused psychotherapy and first-line SSRIs are inadequate. Start 1 mg at bedtime; titrate by 1 mg every 3-5 days to clinical effect; typical effective dose 2-10 mg at bedtime.
Ce fac dacă uit o doză?
Take it as soon as you remember, unless it is nearly time for your next dose — in that case skip the missed dose and resume at the next scheduled time. Do not double up. A single missed dose does not materially affect long-term BP control.
Can I stop Prazopress if my BP is under control?
Alpha-blockers can be stopped without a dedicated tapering protocol, but BP will usually rise if they contributed meaningfully to control. If restarting after a gap of more than 1 week, re-initiate at the starting dose (not the previous maintenance dose) — the first-dose phenomenon returns after a drug-free break.
Can I take Prazopress in pregnancy?
Generally no. Pregnancy antihypertensives of choice are methyldopa, labetalol, and nifedipine — Prazopress is not first-line in pregnancy. Switch to one of those before conception or as soon as pregnancy is confirmed, under specialist supervision.
Where can I buy Prazopress online?
You can buy Prazopress (1 mg prazosin, 30-90 tablets) from MedsBase with discreet packaging and worldwide shipping.
Related Antihypertensives on MedsBase
- Aldactone — Spironolactone 25/50/100 mg (PATHWAY-2 4th-line)
- Amlode — Amlodipine 5/10 mg (CCB)
- Clodict — Clonidine 100 mcg
- Minipress XL — Prazosin ER 2.5/5 mg (Pfizer)
- Prazopress XL — Prazosin ER 2.5/5 mg (Sun Pharma)
- Telma H — Telmisartan + HCTZ combination
- Browse all High Blood Pressure Medications


































Recenzii
Nu există recenzii încă